Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDORA trial of cannabidiol for aromatase inhibitor-associated joint pain in early breast cancer
2023-505380-36-01Phase 3Authorised
- Sponsor
- Gustave Roussy
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol in Musculoskeletal pain and breast cancer (2 arms), sponsored by Gustave Roussy. Primary endpoint: Average joint pain. Planned start Sep 2024; status: authorised.
02
Drugs
cannabidiol
03
Conditions
Musculoskeletal painbreast cancer
Beyond the preview
Go deeper on 2023-505380-36-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505380-36-01.